Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-03
2007-04-03
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S131000
Reexamination Certificate
active
10515192
ABSTRACT:
The present invention encompasses compounds of Formula I: as well as the pharmaceutically acceptable salts and hydrates thereof. The compounds are useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. Pharmaceutical compositions and methods of use are included.
REFERENCES:
patent: 4096273 (1978-06-01), Gutman
patent: 6200978 (2001-03-01), Maw et al.
patent: 6277873 (2001-08-01), Yu et al.
patent: 0454444 (1991-04-01), None
patent: 1070708 (2000-07-01), None
patent: WO 97/44333 (1997-11-01), None
patent: WO98/31681 (1998-07-01), None
patent: WO 00/00477 (2000-01-01), None
patent: WO02/06269 (2002-01-01), None
Rice et al., “An Improved Synthesis of 1,2,4-Oxadizaoles on Solid Support,” Bioorganic Medicinal Chemistry Letters, vol. 11, pp. 753-755 (2001).
Chen Weirong
Hale Jeffrey J.
Li Zhen
Lynch Christopher L.
Mills Sander G.
Freistein Andrew B.
Merck & Co. , Inc.
Rose David L.
Saeed Kamal A.
Yuro Raynard
LandOfFree
1-((5-aryl-1,2,4-oxadiazol-3-yl)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-((5-aryl-1,2,4-oxadiazol-3-yl)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-((5-aryl-1,2,4-oxadiazol-3-yl)... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3781450